Company Filing History:
1 out of 624 
1 out of 2 Years Active: 2024
Title: Beom Seon Suh: Innovator in Heterocyclic Compounds
Introduction
Beom Seon Suh is a notable inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of chemical technology, particularly in the development of novel compounds for medical applications. His work focuses on innovative solutions for treating various diseases, including cancer and autoimmune disorders.
Latest Patents
Beom Seon Suh holds a patent for a bifunctional heterocyclic compound that has a Bruton's tyrosine kinase (BTK) degradation function via the ubiquitin proteasome pathway. This invention is particularly relevant for preventing or treating cancer, autoimmune diseases, and inflammatory conditions. The compound represents a promising advancement in therapeutic options for diseases such as Parkinson's disease.
Career Highlights
Throughout his career, Beom Seon Suh has worked with esteemed organizations, including the Korea Research Institute of Chemical Technology and Ubix Therapeutics, Inc. His experience in these institutions has allowed him to refine his expertise in chemical research and development.
Collaborations
Beom Seon Suh has collaborated with notable colleagues, including Pil Ho Kim and Sung Yun Cho. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Beom Seon Suh is a distinguished inventor whose work in heterocyclic compounds has the potential to impact the treatment of serious medical conditions. His innovative approach and dedication to research continue to pave the way for future advancements in the field.